Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 1589 contracts
Samples: Securities Purchase Agreement (Akoustis Technologies, Inc.), Securities Purchase Agreement (Volato Group, Inc.), Securities Purchase Agreement (GT Biopharma, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 1582 contracts
Samples: Securities Purchase Agreement (Presto Automation Inc.), Securities Purchase Agreement (Interactive Strength, Inc.), Securities Purchase Agreement (GeoVax Labs, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 291 contracts
Samples: Market Offering Agreement (eFFECTOR Therapeutics, Inc.), Market Offering Agreement (eFFECTOR Therapeutics, Inc.), Securities Purchase Agreement (Bridger Aerospace Group Holdings, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 240 contracts
Samples: Market Offering Agreement (Ascent Solar Technologies, Inc.), Underwriting Agreement (ENDRA Life Sciences Inc.), Underwriting Agreement (Peraso Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 160 contracts
Samples: Underwriting Agreement (MED EIBY Holding Co., LTD), Securities Purchase Agreement (Alpha Teknova, Inc.), Securities Purchase Agreement (Alpha Teknova, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 113 contracts
Samples: Securities Purchase Agreement (HyreCar Inc.), Convertible Note Purchase Agreement (Logiq, Inc.), Securities Purchase Agreement (CooTek(Cayman)Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 90 contracts
Samples: Securities Purchase Agreement (SinglePoint Inc.), Market Offering Agreement (Cleanspark, Inc.), Securities Purchase Agreement (Bruush Oral Care Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 80 contracts
Samples: Exchange Agreement (Quad M Solutions, Inc.), Securities Purchase Agreement (Reign Sapphire Corp), Securities Purchase Agreement (Creative Medical Technology Holdings, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 78 contracts
Samples: Securities Purchase Agreement (Comstock Inc.), Securities Purchase Agreement (Stemtech Corp), Securities Purchase Agreement (CarbonMeta Technologies, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“"OFAC”").
Appears in 58 contracts
Samples: Securities Purchase Agreement (Flora Growth Corp.), Securities Purchase and Exchange Agreement (Volcon, Inc.), Securities Purchase and Exchange Agreement (Volcon, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary norSubsidiary, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 31 contracts
Samples: Placement Agency Agreement (GeoVax Labs, Inc.), Placement Agency Agreement (ENDRA Life Sciences Inc.), Placement Agency Agreement (CNS Pharmaceuticals, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 30 contracts
Samples: Securities Purchase Agreement (Smith Micro Software, Inc.), Securities Purchase Agreement (Momentus Inc.), Securities Purchase Agreement (Intercontinental Exchange, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary norSubsidiary, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 29 contracts
Samples: Securities Purchase Agreement (Invivo Therapeutics Holdings Corp.), Securities Purchase Agreement (Invivo Therapeutics Holdings Corp.), Securities Purchase Agreement (Invivo Therapeutics Holdings Corp.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, nor any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 29 contracts
Samples: Securities Purchase Agreement (MDNA Life Sciences, Inc.), Loan Agreement (Luxurban Hotels Inc.), Exchange Agreement (Edible Garden AG Inc)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 25 contracts
Samples: Securities Purchase Agreement (Kartoon Studios, Inc.), Securities Purchase Agreement (Kartoon Studios, Inc.), Securities Purchase Contract (Nano Labs LTD)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 23 contracts
Samples: Ordinary Share Purchase Agreement (Stealth BioTherapeutics Corp), Share Purchase Agreement (Xenon Pharmaceuticals Inc.), Share Purchase Agreement (Xenon Pharmaceuticals Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 22 contracts
Samples: Securities Purchase Agreement (Adamis Pharmaceuticals Corp), Securities Purchase Agreement (Acurx Pharmaceuticals, Inc.), Securities Purchase Agreement (Acurx Pharmaceuticals, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledgeKnowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 18 contracts
Samples: Stock Purchase Agreement (Yunhong Green Cti Ltd.), Stock Purchase Agreement (Yunhong Green Cti Ltd.), Securities Purchase Agreement (Range Impact, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 17 contracts
Samples: Securities Purchase Agreement (Acurx Pharmaceuticals, Inc.), Securities Purchase Agreement (Adamis Pharmaceuticals Corp), Securities Purchase Agreement (U.S. Gold Corp.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. United States sanctions administered by the Office of Foreign Assets Control of the U.S. United States Treasury Department (“OFAC”).
Appears in 16 contracts
Samples: Securities Purchase Agreement (Energy Focus, Inc/De), Consent and Waiver (Oncocyte Corp), Unit Purchase Agreement (ASLAN Pharmaceuticals LTD)
Office of Foreign Assets Control. Neither the Company nor or any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 15 contracts
Samples: Securities Purchase Agreement (Black Hawk Exploration), Loan Agreement (Black Hawk Exploration), Securities Purchase Agreement (Geoglobal Resources Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 14 contracts
Samples: Underwriting Agreement (SeqLL, Inc.), Underwriting Agreement (SeqLL, Inc.), Underwriting Agreement (SeqLL, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, joint venture employee or affiliate of the Company or any Subsidiary is currently currently, or in the past 5 years, has been subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 12 contracts
Samples: Securities Purchase Agreement (Madison Technologies Inc.), Exchange Agreement (Charge Enterprises, Inc.), Securities Purchase Agreement (Charge Enterprises, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 12 contracts
Samples: Underwriting Agreement (Titan Pharmaceuticals Inc), Underwriting Agreement (Titan Pharmaceuticals Inc), Underwriting Agreement (Titan Pharmaceuticals Inc)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee employee, or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 11 contracts
Samples: Underwriting Agreement (Lafayette Energy Corp.), Underwriting Agreement (Grom Social Enterprises, Inc.), Underwriting Agreement (Grom Social Enterprises, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate controlled Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 10 contracts
Samples: Securities Purchase Agreement (Wisa Technologies, Inc.), Securities Purchase Agreement (Wisa Technologies, Inc.), Securities Purchase Agreement (Wisa Technologies, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledgeKnowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 9 contracts
Samples: Securities Purchase Agreement (Alzamend Neuro, Inc.), Securities Purchase Agreement (Alzamend Neuro, Inc.), Securities Purchase Agreement (Ault Alliance, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or controlled affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 9 contracts
Samples: Securities Purchase Agreement (Wisa Technologies, Inc.), Securities Purchase Agreement (Wisa Technologies, Inc.), Securities Purchase Agreement (Wisa Technologies, Inc.)
Office of Foreign Assets Control. Neither the Company nor or any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 8 contracts
Samples: Securities Purchase Agreement (Epicept Corp), Securities Purchase Agreement (Epicept Corp), Securities Purchase Agreement (Epicept Corp)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary of its Subsidiaries nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary of its Subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 8 contracts
Samples: Securities Purchase Agreement (Kaival Brands Innovations Group, Inc.), Securities Purchase Agreement (Edible Garden AG Inc), Securities Purchase Agreement (Cheetah Net Supply Chain Service Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 7 contracts
Samples: Securities Purchase Agreement (Transphorm, Inc.), Securities Purchase Agreement (Transphorm, Inc.), Securities Purchase Agreement (Transphorm, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s its knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 7 contracts
Samples: Securities Purchase Agreement (Ominto, Inc.), Securities Purchase Agreement (Ominto, Inc.), Placement Agency Agreement (Ominto, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 7 contracts
Samples: Subscription Agreement (Odyssey Semiconductor Technologies, Inc.), Subscription Agreement, Subscription Agreement (Odyssey Semiconductor Technologies, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 7 contracts
Samples: Underwriting Agreement (Focus Universal Inc.), Underwriting Agreement (Achieve Life Sciences, Inc.), Underwriting Agreement (Achieve Life Sciences, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary norSubsidiary, to the Company’s knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 7 contracts
Samples: Placement Agency Agreement (My Size, Inc.), Placement Agent Agreement (Q BioMed Inc.), Placement Agent Agreement (Q BioMed Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary is currently subject to any U.S. United States sanctions administered by the Office of Foreign Assets Control of the U.S. United States Treasury Department (“OFAC”).
Appears in 7 contracts
Samples: Underwriting Agreement (Unusual Machines, Inc.), Underwriting Agreement (Unusual Machines, Inc.), Underwriting Agreement (Unusual Machines, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary Subsidiary, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 6 contracts
Samples: Lock Up Agreement (Applied UV, Inc.), Underwriting Agreement (Applied UV, Inc.), Underwriting Agreement (Applied UV, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 5 contracts
Samples: Securities Purchase Agreement (SANUWAVE Health, Inc.), Securities Purchase Agreement (SANUWAVE Health, Inc.), Securities Purchase Agreement (SANUWAVE Health, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, officer or employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 5 contracts
Samples: Underwriting Agreement (Ceres, Inc.), Underwriting Agreement (Ceres, Inc.), Underwriting Agreement (Ceres, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, agent or employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 5 contracts
Samples: Securities Purchase Agreement (AppTech Payments Corp.), Securities Purchase Agreement (BioCardia, Inc.), Securities Purchase Agreement (Addex Therapeutics Ltd.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Knowledge of the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 5 contracts
Samples: Transaction Agreement (Lilis Energy, Inc.), Securities Purchase Agreement (LIGHTBRIDGE Corp), Securities Purchase Agreement (LIGHTBRIDGE Corp)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. United States sanctions administered by the Office of Foreign Assets Control of the U.S. United States Treasury Department (“OFAC”).
Appears in 5 contracts
Samples: Securities Purchase Agreement (JRjr33, Inc.), Securities Purchase Agreement (Galena Biopharma, Inc.), Securities Purchase Agreement (Tribute Pharmaceuticals Canada Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)) or any similar Israeli sanctions administered by an analogous governmental body in Israel.
Appears in 5 contracts
Samples: Securities Purchase Agreement (DarioHealth Corp.), Securities Purchase Agreement (DarioHealth Corp.), Securities Purchase Agreement (DarioHealth Corp.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, or employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 5 contracts
Samples: Underwriting Agreement (Medlab Clinical Ltd.), Underwriting Agreement (Medlab Clinical Ltd.), Underwriting Agreement (XORTX Therapeutics Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 5 contracts
Samples: Securities Purchase Agreement (Elutia Inc.), Securities Purchase Agreement (Kiora Pharmaceuticals Inc), Market Offering Agreement (Greenland Technologies Holding Corp.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, agent or employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 5 contracts
Samples: Underwriting Agreement (Windtree Therapeutics Inc /De/), Underwriting Agreement (Windtree Therapeutics Inc /De/), Underwriting Agreement (Windtree Therapeutics Inc /De/)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or controlled affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 5 contracts
Samples: Securities Purchase Agreement (Biolase, Inc), Securities Purchase Agreement (Biolase, Inc), Securities Purchase Agreement (Biolase, Inc)
Office of Foreign Assets Control. Neither the Company Company, nor any Subsidiary Subsidiary, nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 5 contracts
Samples: Securities Purchase Agreement (Nuwellis, Inc.), Securities Purchase Agreement (Nuwellis, Inc.), Securities Purchase Agreement (Nuwellis, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary Subsidiary, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 5 contracts
Samples: Securities Purchase Agreement (Mitesco, Inc.), Securities Purchase Agreement (Vocodia Holdings Corp), Securities Purchase Agreement (Vocodia Holdings Corp)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary Company, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 5 contracts
Samples: Underwriting Agreement (Clarus Therapeutics Holdings, Inc.), Underwriting Agreement (Clarus Therapeutics Holdings, Inc.), Underwriting Agreement (Clarus Therapeutics Holdings, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Company, the Subsidiary nor, to the Knowledge of the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 4 contracts
Samples: Form of Securities Purchase Agreement (Integrity Applications, Inc.), Securities Purchase Agreement (Integrity Applications, Inc.), Form of Securities Purchase Agreement (Integrity Applications, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (or has engaged in business in an “OFAC”)enemy state” pursuant to the Israeli Trade with the Enemy Ordinance, 1939.
Appears in 4 contracts
Samples: Securities Purchase Agreement (PolyPid Ltd.), Underwriting Agreement (PolyPid Ltd.), Securities Purchase Agreement (PolyPid Ltd.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary of its Subsidiaries nor, to the knowledge of the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary of its Subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 4 contracts
Samples: Purchase Agreement (Owens Corning/Fibreboard Asbestos Personal Injury Trust), Purchase Agreement (Owens Corning), Purchase Agreement (Owens Corning/Fibreboard Asbestos Personal Injury Trust)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, or employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 4 contracts
Samples: Underwriting Agreement (Huadi International Group Co., Ltd.), Underwriting Agreement (Painreform Ltd.), Underwriting Agreement (Powerbridge Technologies Co., Ltd.)
Office of Foreign Assets Control. Neither the Company Company, nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 4 contracts
Samples: Securities Purchase Agreement (Quantum Computing Inc.), Subscription Instructions (Quantum Computing Inc.), Securities Purchase Agreement (Arqule Inc)
Office of Foreign Assets Control. Neither the Company Company, nor any Subsidiary Subsidiary, nor, to the Company’s knowledge, any director, officer, agent, employee or controlled affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 4 contracts
Samples: Securities Purchase Agreement (Wisa Technologies, Inc.), Securities Purchase Agreement (Wisa Technologies, Inc.), Securities Purchase Agreement (Nuwellis, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department Department. (“OFAC”gg).
Appears in 4 contracts
Samples: Underwriting Agreement (Dolphin Entertainment, Inc.), Underwriting Agreement (Dolphin Entertainment, Inc.), Underwriting Agreement (Dolphin Entertainment, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee employee, affiliate or affiliate other Persons acting on behalf of the Company or any Subsidiary is currently subject to any U.S. applicable sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 4 contracts
Samples: Securities Purchase Agreement (Inhibikase Therapeutics, Inc.), Securities Purchase Agreement (BriaCell Therapeutics Corp.), Securities Purchase Agreement (Inhibikase Therapeutics, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, joint venture employee or affiliate of the Company or any Subsidiary is currently currently, or in the past 5 years, been subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 4 contracts
Samples: Securities Purchase Agreement (Charge Enterprises, Inc.), Securities Purchase Agreement (Charge Enterprises, Inc.), Securities Purchase Agreement (Charge Enterprises, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 4 contracts
Samples: Underwriting Agreement (ADiTx Therapeutics, Inc.), Underwriting Agreement (ADiTx Therapeutics, Inc.), Underwriting Agreement (ADiTx Therapeutics, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary of its Subsidiaries nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Imperalis Holding Corp.), Share Exchange Agreement (TimefireVR Inc.), Share Exchange Agreement (Riot Blockchain, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary Subsidiary, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 3 contracts
Samples: Securities Purchase Agreement (S&W Seed Co), Securities Purchase Agreement (Wynnefield Partners Small Cap Value Lp), Securities Purchase Agreement (S&W Seed Co)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate Person acting on behalf of the Company or any Subsidiary Company, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 3 contracts
Samples: Confidential Treatment Requested (Ultragenyx Pharmaceutical Inc.), Common Stock Purchase Agreement (MEI Pharma, Inc.), Confidential Treatment Requested (Ultragenyx Pharmaceutical Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee employee, or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Yoshitsu Co., LTD), Securities Purchase Agreement (theMaven, Inc.), Securities Purchase Agreement (Verb Technology Company, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary Subsidiary, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“"OFAC”").
Appears in 3 contracts
Samples: Securities Purchase Agreement (S&W Seed Co), Securities Purchase Agreement (S&W Seed Co), Securities Purchase Agreement (S&W Seed Co)
Office of Foreign Assets Control. Neither the Company Purchaser nor any Subsidiary nor, to the CompanyPurchaser’s knowledge, any director, officer, agent, employee or affiliate of the Company Purchaser or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (NextPlat Corp), Securities Purchase Agreement (NextPlat Corp), Securities Purchase Agreement (Progressive Care Inc.)
Office of Foreign Assets Control. Neither the Company nor any Private Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Private Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Fortress Biotech, Inc.), Securities Purchase Agreement (Fortress Biotech, Inc.), Securities Purchase Agreement (Fortress Biotech, Inc.)
Office of Foreign Assets Control. Neither the Company nor any the Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any the Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Surna Inc.), Securities Purchase and Registration Rights Agreement (AIT Therapeutics, Inc.), Securities Purchase and Registration Rights Agreement (AIT Therapeutics, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 3 contracts
Samples: Underwriting Agreement (Coeptis Therapeutics Holdings, Inc.), Underwriting Agreement (Hancock Jaffe Laboratories, Inc.), Underwriting Agreement (Hancock Jaffe Laboratories, Inc.)
Office of Foreign Assets Control. Neither neither the Company company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Celsion CORP), Securities Purchase Agreement (Celsion CORP), Securities Purchase Agreement (Celsion CORP)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary norSubsidiary, to the Company’s 's knowledge, any director, officer, agent, or employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Placement Agent Agreement (Transphorm, Inc.), Placement Agent Agreement (Transphorm, Inc.), Placement Agent Agreement (Audioeye Inc)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 3 contracts
Samples: Underwriting Agreement (Innovation Beverage Group LTD), Underwriting Agreement (Innovation Beverage Group LTD), Underwriting Agreement (Innovation Beverage Group LTD)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary northe Subsidiary, and to the Company’s knowledge, any no director, officer, agent, employee or affiliate of the Company or any the Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Convertible Note Purchase Agreement (Data443 Risk Mitigation, Inc.), Convertible Note Purchase Agreement (Data443 Risk Mitigation, Inc.), Convertible Note Purchase Agreement (Data443 Risk Mitigation, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary of its subsidiaries nor, to the knowledge of the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary of its subsidiaries is currently subject to any U.S. sanctions administered by OFAC; and the Office of Foreign Assets Control Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. Treasury Department (“sanctions administered by OFAC”).
Appears in 3 contracts
Samples: Underwriting Agreement (Enduro Royalty Trust), Underwriting Agreement (Enduro Royalty Trust), Underwriting Agreement (Enduro Royalty Trust)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary Subsidiary, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Resonate Blends, Inc.), Securities Purchase Agreement (Elephant Oil Corp.), Securities Purchase Agreement (Elephant Oil Corp.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary norCompany, and to the Company’s knowledge, nor any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary Company, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 3 contracts
Samples: Exchange and Settlement Agreement (Infinity Energy Resources, Inc), Exchange Agreement (Infinity Energy Resources, Inc), Exchange Agreement (Infinity Energy Resources, Inc)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)..
Appears in 3 contracts
Samples: Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd.), Securities Purchase Agreement (Neptune Wellness Solutions Inc.), Securities Purchase Agreement (Quoin Pharmaceuticals, Ltd.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).. (nn)
Appears in 3 contracts
Samples: Securities Purchase Agreement (Future Healthcare of America), Securities Purchase Agreement (Anpath Group, Inc.), Securities Purchase Agreement (Accurexa Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, or to the Company’s knowledgeknowledge any Subsidiary nor, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Neuralstem, Inc.), Securities Purchase Agreement (Neuralstem, Inc.), Securities Purchase Agreement (Neuralstem, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary Company, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Inspire Veterinary Partners, Inc.), Securities Purchase Agreement (Paid Inc), Securities Purchase Agreement (Paid Inc)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary Subsidiary, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”’).
Appears in 3 contracts
Samples: Subscription Agreement (Marina Biotech, Inc.), Subscription Agreement (Adhera Therapeutics, Inc.), Subscription Agreement (Adhera Therapeutics, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“”OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (TFF Pharmaceuticals, Inc.), Securities Purchase Agreement (Creatd, Inc.), Securities Purchase Agreement (Creatd, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary he Company, nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Protalex Inc), Securities Purchase Agreement (Protalex Inc), Securities Purchase Agreement (Protalex Inc)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledgeKnowledge, any director, manager, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (ABT Holdings, Inc.), Securities Purchase Agreement (Content Checked Holdings, Inc.), Securities Purchase Agreement (Staffing 360 Solutions, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 3 contracts
Samples: Market Offering Agreement (Ampio Pharmaceuticals, Inc.), Underwriting Agreement (Salarius Pharmaceuticals, Inc.), Underwriting Agreement (Digital Turbine, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 3 contracts
Samples: Securities Purchase Agreement (Premier Biomedical Inc), Securities Purchase Agreement (Opgen Inc), Securities Purchase Agreement (Opgen Inc)
Office of Foreign Assets Control. Neither the Company nor any its Subsidiary nor, to the Company’s knowledgeKnowledge, any directorof the current or former directors, officerofficers, agentemployees, employee agents or affiliate other Persons acting on behalf of the Company or any its Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Lyra Therapeutics, Inc.), Securities Purchase Agreement (Lyra Therapeutics, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge's Knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Lattice INC), Securities Purchase Agreement (Umami Sustainable Seafood Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary norSubsidiary, and to the Company’s knowledge, any no director, officer, agent, employee or affiliate of the Company or any Subsidiary Subsidiary, is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 2 contracts
Samples: Placement Agency Agreement (HeartBeam, Inc.), Placement Agency Agreement (HeartBeam, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“"OFAC”").
Appears in 2 contracts
Samples: Placement Agency Agreement (Pershing Gold Corp.), Securities Purchase Agreement (Worldwide Energy & Manufacturing Usa Inc)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary of its subsidiaries nor, to the knowledge of the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”), including without limitation the Iran Threat Reduction and Syria Human Rights Act of 2012.
Appears in 2 contracts
Samples: Underwriting Agreement (JMP Group Inc.), Underwriting Agreement (JMP Group Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“"OFAC”").
Appears in 2 contracts
Samples: Securities Purchase Agreement (Cyclacel Pharmaceuticals, Inc.), Securities Purchase Agreement (NXT-Id, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the United States Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Petroteq Energy Inc.), Securities Purchase Agreement (Petroteq Energy Inc.)
Office of Foreign Assets Control. Neither the Company Company, nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate Affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Talphera, Inc.), Securities Purchase Agreement (Talphera, Inc.)
Office of Foreign Assets Control. Neither None of the Company nor any Subsidiary noror, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 2 contracts
Samples: Secured Convertible Note Purchase Agreement (H-Cyte, Inc.), Secured Convertible Note and Warrant Purchase Agreement (H-Cyte, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary of its subsidiaries nor, to the knowledge of the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“"OFAC”").
Appears in 2 contracts
Samples: Underwriting Agreement (Red Lion Hotels CORP), Underwriting Agreement (Red Lion Hotels CORP)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s 's knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“"OFAC”").
Appears in 2 contracts
Samples: Securities Purchase Agreement (Ironwood Gold Corp.), Securities Purchase Agreement (PishPosh, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Knowledge of the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 2 contracts
Samples: Placement Agency Agreement (Pressure Biosciences Inc), Placement Agency Agreement (Pressure Biosciences Inc)
Office of Foreign Assets Control. Neither the Company nor any Company, its Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”)Department.
Appears in 2 contracts
Samples: Stock Purchase Agreement (Syros Pharmaceuticals, Inc.), Stock Purchase Agreement (Syros Pharmaceuticals, Inc.)
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, agent or employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
Appears in 2 contracts
Samples: Securities Purchase Agreement (Ekso Bionics Holdings, Inc.), Securities Purchase Agreement (Mainz Biomed N.V.)
